Kezdőlap
Mélykutatási eredmények
QA
Jelek
Területek
Módszertan
Névjegy
Keresés
Kutatási jelek – Signal Engine
Long‑Term Follow‑Up of Adjuvant Imatinib for Localized Gastrointestinal Stromal Tumors
— Gastrointestinal stromal tumor
Global Longitudinal Assessment of Treatment Outcomes in Recurrent/Metastatic Nasopharyngeal Carcinoma: GLANCE‑NPC Study
— Nasopharyngeal carcinoma
Systemic Treatments for Unresectable Pleural Mesothelioma: A Review of the Literature
— Malignant pleural mesothelioma
The Role of Interventional Radiology in the Diagnosis and Treatment of Gynecological Conditions
— Endometrial cancer
Health Insurance, Blood Cancer Care, and Outcomes: A Literature Review
— Diffuse large B-cell lymphoma
A Decade of Progress: Advances in the Third-Line Treatment of Patients With Metastatic Colorectal Cancer
— Colorectal cancer
A Molecular Revolution Is Underway in Thoracic Oncology
— NSCLC
Phase 3 Study of Uproleselan for R/R AML to Continue to Final OS Events Trigger
— Acute myeloid leukemia
High Tumor Mutation Burden Predicts Response to Immune Checkpoint Blockade for Some Cancer Types
— NSCLC
Lessons From the Withdrawal of Atezolizumab in Metastatic TNBC
— Thyroid cancer
Major discovery provides new hope for blood cancer patients
— Acute myeloid leukemia
How the Emergence of Immunotherapy has Impacted Practice Patterns for Treatment and Management of Merkel Cell Carcinoma
— Merkel cell carcinoma
Osimertinib with or without savolitinib as first-line treatment for MET‑aberrant, EGFR‑mutant NSCLC: randomized phase 2 trial (FLOWERS)
— NSCLC
Effect of Camrelizumab vs Placebo Added to Chemotherapy on Survival and Progression-Free Survival in Patients With Advanced or Metastatic Esophageal Squamous Cell Carcinoma
— Esophageal cancer
Phase II Trial of Pembrolizumab Plus Gemcitabine, Vinorelbine, and Liposomal Doxorubicin as Second-Line Therapy for Relapsed or Refractory Classical Hodgkin Lymphoma
— Hodgkin lymphoma
Cholangiocarcinoma
— Cholangiocarcinoma
Latest advances in the management of classical Hodgkin lymphoma: the era of novel therapies
— Hodgkin lymphoma
Management of Acute Myeloid Leukemia: A Review
— Acute myeloid leukemia
Lineage-defined leiomyosarcoma subtypes emerge years before diagnosis and determine patient survival
— Leiomyosarcoma
Endometrial Cancer - PMC
— Endometrial cancer
Előző
67/102
Következő